CAS No. |
33069-62-4 |
中文名称 |
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-苯甲酰氨基-2-羟基-3-苯基丙酰基)氧基)-12-(苯甲酰氧基)-4,11-二羟基甲基-4a,8,13,13-四甲基-5-氧代-2a,3,4,4a,5,6,9,10,11,12,12a,12b-十二氢-1H-7,11-甲桥环十二烷并[3,4]苯并[1,2-b]氧杂环丁烷-6,12b-二基 二乙酸酯 |
英文名称 |
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate |
别名 |
NSC125973 | NSC-125973 | Onxal | ORAXOL COMPONENT PACLITAXEL | Pacliex | (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a |
标准英文名 |
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate |
MDL No. |
MFCD00869953 |
分子式 |
C47H51NO14 |
分子量 |
853.92
|
精确分子量 |
853.33
|
SMILES |
CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O |
标准SMILES |
CC1(C)C2[C@@H](OC(C)=O)C(=O)[C@@]3(C)[C@H]([C@H](OC(=O)c4ccccc4)[C@]1(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1)C=2C)[C@@]1(CO[C@@H]1C[C@@H]3O)OC(C)=O |
用途 |
Paclitaxel is an antineoplastic agent used for the treatment of metastatic breast cancer and metastatic ovarian cancer; a broad-spectrum anticancer phytomedicine effective against ovarian cancer, breast cancer, non-small cell lung cancer, small cell lung cancer, colorectal cancer, melanoma, head and neck cancer, lymphoma, brain tumors, prostate cancer, esophageal cancer, germ cell tumors, endometrial cancer, and bladder cancer; a microtubule-stabilizing agent that promotes tubulin polymerization and inhibits depolymerization, thereby arresting cell division at the G2/M phase of the cell cycle; an anti-microtubule drug that binds to the N-terminal region of β-tubulin, forming highly stable microtubules resistant to depolymerization, thus blocking normal mitosis; exhibits potent activity against human endothelial cells with an IC50 of 0.1 pM. |
InChIKey |
RCINICONZNJXQF-MZXODVADSA-N |